{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T13:40:54Z","timestamp":1762522854773,"version":"3.41.2"},"reference-count":43,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,11,9]],"date-time":"2023-11-09T00:00:00Z","timestamp":1699488000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec><jats:title>Purpose<\/jats:title><jats:p>The study aimed to compare the dosimetric distribution of VMAT plans by increasing the number of half arcs in liver SBRT and investigate the effect by using automatic plan software in plan optimization.<\/jats:p><\/jats:sec><jats:sec><jats:title>Method<\/jats:title><jats:p>Thirty-one patients with oligo liver tumors were randomly selected. VMAT treatment plans with different numbers of coplanar half arcs were generated.<\/jats:p><\/jats:sec><jats:sec><jats:title>Result<\/jats:title><jats:p>Adding arcs significantly increased the PTV, <jats:italic>D<jats:sub>2%<\/jats:sub><\/jats:italic>, <jats:italic>D<jats:sub>50%<\/jats:sub><\/jats:italic>, and <jats:italic>CI<\/jats:italic>, but sacrificed the plan homogeneity. It also decreased the maximum dose of normal tissues such as the stomach, duodenum, and spinal cord and reduced <jats:italic>D<jats:sub>mean<\/jats:sub><\/jats:italic>, <jats:italic>D<jats:sub>500cc<\/jats:sub><\/jats:italic>, and <jats:italic>D<jats:sub>700cc<\/jats:sub><\/jats:italic> for the liver. Nevertheless, the diminishing effect gradually decayed into three arcs. Meanwhile, the addition of arcs substantially extended the beam-on time.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>In the context of SBRT for oligo liver tumors, increasing the number of coplanar half arcs will improve PTV conformity and offer better protection for OARs, albeit at the expense of increased treatment duration. Considering the trade-off between plan quality and treatment efficiency, a three-arc plan may be more suitable for clinical implementation.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fonc.2023.1273042","type":"journal-article","created":{"date-parts":[[2023,11,13]],"date-time":"2023-11-13T02:54:17Z","timestamp":1699844057000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Dosimetric comparison in sparing normal tissue dosage by using auto-SBRT planning in oligo liver tumors"],"prefix":"10.3389","volume":"13","author":[{"given":"Shu","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiyi","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ni","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiangping","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maoqi","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenjun","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nianyong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianghong","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,11,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"16018","DOI":"10.1038\/nrdp.2016.18","article-title":"Hepatocellular carcinoma","volume":"2","author":"Llovet","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)30010-2","article-title":"Hepatocellular carcinoma","volume":"391","author":"Forner","year":"2018","journal-title":"Lancet"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.25997","article-title":"Stereotactic body radiotherapy for colorectal liver metastases: a pooled analysis","volume":"117","author":"Chang","year":"2011","journal-title":"Cancer"},{"key":"B4","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s13014-018-0969-2","article-title":"Stereotactic Body Radiotherapy (SBRT) for liver metastasis - clinical outcomes from the international multi-institutional RSSearch(R) Patient Registry","volume":"13","author":"Mahadevan","year":"2018","journal-title":"Radiat Oncol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"9","DOI":"10.21037\/cco-20-89","article-title":"Efficacy and safety of radiotherapy for primary liver cancer","volume":"10","author":"Chen","year":"2021","journal-title":"Chin Clin Oncol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.prro.2015.02.007","article-title":"Treatment variables related to liver toxicity in patients with hepatocellular carcinoma, Child-Pugh class A and B enrolled in a phase 1-2 trial of stereotactic body radiation therapy","volume":"5","author":"Lasley","year":"2015","journal-title":"Pract Radiat Oncol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.44.1659","article-title":"Sequential phase I and II trials of stereotactic body radiotherapy for locally advanced hepatocellular carcinoma","volume":"31","author":"Bujold","year":"2013","journal-title":"J Clin Oncol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2018.01.004","article-title":"A prospective study of the safety and efficacy of liver stereotactic body radiotherapy in patients with and without prior liver-directed therapy","volume":"126","author":"Moon","year":"2018","journal-title":"Radiother Oncol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-020-03223-9","article-title":"Stereotactic body radiotherapy (SBRT) can delay polymetastatic conversion in patients affected by liver oligometastases","volume":"146","author":"Nicosia","year":"2020","journal-title":"J Cancer Res Clin Oncol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/1748-717X-6-76","article-title":"Volumetric intensity-modulated Arc (RapidArc) therapy for primary hepatocellular carcinoma: comparison with intensity-modulated radiotherapy and 3-D conformal radiotherapy","volume":"6","author":"Kuo","year":"2011","journal-title":"Radiat Oncol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v22.i32.7311","article-title":"Technical advances in external radiotherapy for hepatocellular carcinoma","volume":"22","author":"Park","year":"2016","journal-title":"World J Gastroenterol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.31334","article-title":"The role of external beam radiotherapy in the treatment of hepatocellular cancer","volume":"124","author":"Chino","year":"2018","journal-title":"Cancer"},{"key":"B13","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.adro.2015.12.004","article-title":"Viability of non-coplanar VMAT for liver SBRT as compared to coplanar VMAT and beam orientation optimized 4pi IMRT","volume":"1","author":"Woods","year":"2016","journal-title":"Adv Radiat Oncol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.radonc.2017.02.018","article-title":"VMAT plus a few computer-optimized non-coplanar IMRT beams (VMAT+) tested for liver SBRT","volume":"123","author":"Sharfo","year":"2017","journal-title":"Radiother Oncol"},{"key":"B15","article-title":"A dosimetric comparison between volumetric-modulated arc therapy and dynamic conformal arc therapy in SBRT","volume":"24","author":"Stathakis","year":"2019","journal-title":"J BUON"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/0360-3016(95)00060-C","article-title":"Toxicity criteria of the radiation therapy oncology group (RTOG) and the european organization for research and treatment of cancer (EORTC)","volume":"31","author":"Cox","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/0360-3016(91)90171-Y","article-title":"Tolerance of normal tissue to therapeutic irradiation","volume":"21","author":"Emami","year":"1991","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B18","doi-asserted-by":"publisher","first-page":"S94","DOI":"10.1016\/j.ijrobp.2009.06.092","article-title":"Radiation-associated liver injury","volume":"76","author":"Pan","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.4251\/wjgo.v11.i5.367","article-title":"Stereotactic body radiation therapy in patients with hepatocellular carcinoma: A mini-review","volume":"11","author":"Gerum","year":"2019","journal-title":"World J Gastrointest Oncol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2007.11.040","article-title":"Can all centers plan intensity-modulated radiotherapy (IMRT) effectively? An external audit of dosimetric comparisons between three-dimensional conformal radiotherapy and IMRT for adjuvant chemoradiation for gastric cancer","volume":"71","author":"Chung","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2005.08.003","article-title":"IMRT treatment planning:- a comparative inter-system and inter-centre planning exercise of the ESTRO QUASIMODO group","volume":"76","author":"Bohsung","year":"2005","journal-title":"Radiother Oncol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"e13714","DOI":"10.1002\/acm2.13714","article-title":"Treatment plan comparison of volumetric-modulated arc therapy to intensity-modulated radiotherapy in lung stereotactic body radiotherapy using either 6- or 10-MV photon energies","volume":"23","author":"Wei","year":"2022","journal-title":"J Appl Clin Med Phys"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1007\/s12094-023-03196-4","article-title":"Automated treatment planning for liver cancer stereotactic body radiotherapy","volume":"25","author":"He","year":"2023","journal-title":"Clin Transl Oncol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s13014-021-01891-6","article-title":"Influence of target dose heterogeneity on dose sparing of normal tissue in peripheral lung tumor stereotactic body radiation therapy","volume":"16","author":"Wei","year":"2021","journal-title":"Radiat Oncol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.ijrobp.2021.09.027","article-title":"A story of hypofractionation and the table on the wall","volume":"112","author":"Timmerman","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3171\/jns.2000.93.supplement_3.0219","article-title":"A simple scoring ratio to index the conformity of radiosurgical treatment plans. Technical note","author":"Paddick","year":"2000","journal-title":"J Neurosurg"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.19.6329","article-title":"Multi-institutional phase I\/II trial of stereotactic body radiation therapy for liver metastases","volume":"27","author":"Rusthoven","year":"2009","journal-title":"J Clin Oncol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1748-717X-9-18","article-title":"Feasibility of stereotactic body radiation therapy with volumetric modulated arc therapy and high intensity photon beams for hepatocellular carcinoma patients","volume":"9","author":"Wang","year":"2014","journal-title":"Radiat Oncol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"4853","DOI":"10.3390\/cancers13194853","article-title":"Image-guided liver stereotactic body radiotherapy using VMAT and real-time adaptive tumor gating: evaluation of the efficacy and toxicity for hepatocellular carcinoma","volume":"13","author":"Cantaloube","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B30","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1002\/acm2.12764","article-title":"FFF-VMAT for SBRT of lung lesions: Improves dose coverage at tumor-lung interface compared to flattened beams","volume":"21","author":"Pokhrel","year":"2020","journal-title":"J Appl Clin Med Phys"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1007\/s13566-016-0289-9","article-title":"Stereotactic body radiation therapy (SBRT) for centrally located primary and recurrent non-small cell lung cancer (NSCLC): analysis of toxicity and local control","volume":"6","author":"Bowers","year":"2017","journal-title":"J Radiat Oncol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1007\/s00066-020-01603-1","article-title":"Definition and quality requirements for stereotactic radiotherapy: consensus statement from the DEGRO\/DGMP Working Group Stereotactic Radiotherapy and Radiosurgery","volume":"196","author":"Guckenberger","year":"2020","journal-title":"Strahlenther Onkol"},{"key":"B33","first-page":"61","article-title":"Intracranial stereotactic radiosurgery","volume":"63","author":"Fanous","year":"2019","journal-title":"J Neurosurg Sci"},{"key":"B34","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s13014-019-1211-6","article-title":"Impact of beam configuration on VMAT plan quality for Pinnacle(3)Auto-Planning for head and neck cases","volume":"14","author":"Richter","year":"2019","journal-title":"Radiat Oncol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.22034\/APJCP.2017.18.5.1395","article-title":"Dosimetric comparison between single and dual arc-volumetric modulated arc radiotherapy and intensity modulated radiotherapy for nasopharyngeal carcinoma using a simultaneous integrated boost technique","volume":"18","author":"Radhakrishnan","year":"2017","journal-title":"Asian Pac J Cancer Prev"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2005.01.002","article-title":"A phase I trial of stereotactic body radiation therapy (SBRT) for liver metastases","volume":"62","author":"Schefter","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1007\/s12094-010-0492-x","article-title":"Phase I feasibility trial of stereotactic body radiation therapy for primary hepatocellular carcinoma","volume":"12","author":"Cardenes","year":"2010","journal-title":"Clin Transl Oncol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2011.04.011","article-title":"Stereotactic body radiotherapy for primary hepatocellular carcinoma","volume":"81","author":"Andolino","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/0360-3016(94)00428-N","article-title":"Clinical radiation nephropathy","volume":"31","author":"Cassady","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2007.12.009","article-title":"Impact of drug therapy, radiation dose, and dose rate on renal toxicity following bone marrow transplantation","volume":"71","author":"Cheng","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1118\/1.3438081","article-title":"Stereotactic body radiation therapy: the report of AAPM Task Group 101","volume":"37","author":"Benedict","year":"2010","journal-title":"Med Phys"},{"key":"B42","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.radonc.2009.11.004","article-title":"Stereotactic body radiotherapy for unresectable cholangiocarcinoma","volume":"94","author":"Kopek","year":"2010","journal-title":"Radiother Oncol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2012.06.005","article-title":"Predictor of severe gastroduodenal toxicity after stereotactic body radiotherapy for abdominopelvic Malignancies","volume":"84","author":"Bae","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2023.1273042\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,13]],"date-time":"2023-11-13T02:54:23Z","timestamp":1699844063000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2023.1273042\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,9]]},"references-count":43,"alternative-id":["10.3389\/fonc.2023.1273042"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2023.1273042","relation":{},"ISSN":["2234-943X"],"issn-type":[{"type":"electronic","value":"2234-943X"}],"subject":[],"published":{"date-parts":[[2023,11,9]]},"article-number":"1273042"}}